Clearstead Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Clearstead Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86.9K	Buy	305 +5	+2%	+$1.47K	﹤0.01%	1333
2026 Q1	$89.1K	Hold	300	–	–	﹤0.01%	1161
2025 Q4	$91.1K	Hold	300	–	–	﹤0.01%	1154
2025 Q3	$102K	Sell	300 -14	-4%	-$4.25K	﹤0.01%	1049
2025 Q2	$76K	Hold	314	–	–	﹤0.01%	1150
2025 Q1	$85.5K	Sell	314 -87	-22%	-$20.3K	﹤0.01%	1025
2024 Q4	$74.1K	Buy	401 +2	+0.5%	+$409	﹤0.01%	1079
2024 Q3	$89.6K	Sell	399 -79	-17%	-$14.2K	﹤0.01%	1057
2024 Q2	$68.2K	Buy	478 +168	+54%	+$25.9K	﹤0.01%	1090
2024 Q1	$50.3K	Hold	310	–	–	﹤0.01%	756
2023 Q4	$55.9K	Buy	310 +4	+1%	+$724	﹤0.01%	713
2023 Q3	$55K	Buy	306 +6	+2%	+$1.19K	﹤0.01%	680
2023 Q2	$53.5K	Hold	300	–	–	﹤0.01%	720
2023 Q1	$64.7K	Hold	300	–	–	﹤0.01%	609
2022 Q4	$66K	Hold	300	–	–	0.01%	578
2022 Q3	$40K	Hold	300	–	–	﹤0.01%	654
2022 Q2	$49K	Hold	300	–	–	﹤0.01%	627
2022 Q1	$57K	Hold	300	–	–	﹤0.01%	653
2021 Q4	$81K	Hold	300	–	–	0.01%	570
2021 Q3	$109K	Hold	300	–	–	0.01%	467
2021 Q2	$103K	Hold	300	–	–	0.01%	448
2021 Q1	$104K	Hold	300	–	–	0.01%	431
2020 Q4	$78K	Hold	300	–	–	0.01%	455
2020 Q3	$86K	Hold	300	–	–	0.01%	391
2020 Q2	$57K	Hold	300	–	–	0.01%	417
2020 Q1	$37K	Buy	+300	New	+$46.9K	0.01%	444

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Clearstead Advisors's ONC Position: Q2 2026 in Review

Clearstead Advisors increased its BeOne Medicines Ltd (ONC) stake by 1.7% in Q2 2026, buying an estimated $1.47K and bringing the position to 305 shares worth $86.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

Clearstead Advisors first reported a position in ONC in Q1 2020 and has held it in 26 quarters since. The position peaked at $109K in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Clearstead Advisors held 305 shares of BeOne Medicines Ltd worth $86.9K as of Q2 2026.
Clearstead Advisors bought 5 BeOne Medicines Ltd shares in Q2 2026, an estimated $1.47K.
BeOne Medicines Ltd made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1333 holding.
Clearstead Advisors first reported a position in BeOne Medicines Ltd in Q1 2020 and has held it in 26 quarters since.
Clearstead Advisors's BeOne Medicines Ltd position peaked at $109K in Q3 2021.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.